FDA Clearance Tracker · P960009-S304
Activa Deep Brain Stimulation Therapy System
Last checked: Nov 20, 2026Latest source record: May 26, 2018 (this decision)Source: openFDAMethods & limitations
Decided
May 26, 2018
Approved
Time to decision
191 days
Received Nov 16, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P960009-S304
- Device name
- Activa Deep Brain Stimulation Therapy System
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Nov 16, 2017
- Decided
- May 26, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P960009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for Medtronics new model A610 Activa Clinician Programmer application and Model 8880T2 Communicator intended for programming DBS systems and for a field-implementable update to the Model 37612 Activa RC implantable neurostimulator to extend the service life from 9 years to 15 years.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.